Literature DB >> 11470010

Statins and blood pressure regulation.

C Borghi1, M Veronesi, M G Prandin, A Dormi, E Ambrosioni.   

Abstract

Hypertension and high serum cholesterol levels are two of the most relevant risk factors for cardiovascular diseases. A combined increase in both risk factors has been reported in a significant proportion of patients with coronary artery disease. Statins are the most widely used drugs to treat hypercholesterolemia, and they interact with blood pressure control in different populations of hypertensive patients. A significant reduction in blood pressure associated with the use of statins has been described in patients with untreated hypertension and in patients treated with antihypertensive drugs, particularly angiotensin converting enzyme inhibitors and calcium channel blockers. The effect of statins on blood pressure control has also been reported in diabetic patients. The mechanisms responsible for the hypotensive effect seem to be largely independent of the effect of statins on lipid profile, and are probably related to their interaction with endothelial function or angiotensin II receptors. The capacity of statins to improve blood pressure control could be a useful consideration for an integrated approach to better prevention of cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11470010     DOI: 10.1007/s11906-001-0090-y

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  42 in total

1.  Effects of simvastatin, an HMG-CoA reductase inhibitor, on plasma lipids and steroid hormones.

Authors:  H Ide; S Fujiya; Y Aanuma; Y Agishi
Journal:  Clin Ther       Date:  1990 Sep-Oct       Impact factor: 3.393

2.  Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men.

Authors:  G Nickenig; A T Bäumer; Y Temur; D Kebben; F Jockenhövel; M Böhm
Journal:  Circulation       Date:  1999-11-23       Impact factor: 29.690

3.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Authors: 
Journal:  JAMA       Date:  1993-06-16       Impact factor: 56.272

4.  Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month.

Authors:  G O'Driscoll; D Green; R R Taylor
Journal:  Circulation       Date:  1997-03-04       Impact factor: 29.690

5.  Effects of lipid-lowering agents in the Dahl salt-sensitive rat.

Authors:  T W Wilson; M Alonso-Galicia; R J Roman
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

6.  Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients.

Authors:  G Tonolo; M G Melis; M Formato; M F Angius; A Carboni; P Brizzi; M Ciccarese; G M Cherchi; M Maioli
Journal:  Eur J Clin Invest       Date:  2000-11       Impact factor: 4.686

7.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

8.  Lovastatin prevents development of hypertension in spontaneously hypertensive rats.

Authors:  J Jiang; R J Roman
Journal:  Hypertension       Date:  1997-10       Impact factor: 10.190

9.  Efficacy and tolerability of lovastatin in hypercholesterolemia in patients with systemic hypertension.

Authors:  R B D'Agostino; W B Kannel; M N Stepanians; L C D'Agostino
Journal:  Am J Cardiol       Date:  1993-01-01       Impact factor: 2.778

10.  Simvastatin treatment of hypercholesterolemia in patients with insulin dependent diabetes mellitus.

Authors:  G Sartor; P Katzman; E Eizyk; J Kalén; A Nilsson; L Ugander; D Ursing
Journal:  Int J Clin Pharmacol Ther       Date:  1995-01       Impact factor: 1.366

View more
  9 in total

Review 1.  Hypertension and lipids: lipid factors in the hypertension syndrome.

Authors:  Gary E Sander; Thomas D Giles
Journal:  Curr Hypertens Rep       Date:  2002-12       Impact factor: 5.369

Review 2.  Immunological aspects of atherosclerosis.

Authors:  S Garrido-Urbani; M Meguenani; F Montecucco; B A Imhof
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

Review 3.  Uncontrolled hypertension as a risk for coronary artery disease: patient characteristics and the role of physician intervention.

Authors:  David J Hyman; Valory N Pavlik
Journal:  Curr Atheroscler Rep       Date:  2003-03       Impact factor: 5.113

4.  Membrane tension modulates the effects of apical cholesterol on the renal epithelial sodium channel.

Authors:  Shi-Peng Wei; Xue-Qi Li; Chu-Fang Chou; You-You Liang; Ji-Bin Peng; David G Warnock; He-Ping Ma
Journal:  J Membr Biol       Date:  2007-10-19       Impact factor: 1.843

Review 5.  Chronic kidney disease: a new look at pathogenetic mechanisms and treatment options.

Authors:  Damien Noone; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2013-03-08       Impact factor: 3.714

6.  Augmentation of the renin-angiotensin system by hypercholesterolemia promotes vascular diseases.

Authors:  Alan Daugherty; Hong Lu; Debra L Rateri; Lisa A Cassis
Journal:  Future Lipidol       Date:  2008-12

Review 7.  Update on statin-mediated anti-inflammatory activities in atherosclerosis.

Authors:  Fabrizio Montecucco; François Mach
Journal:  Semin Immunopathol       Date:  2009-05-05       Impact factor: 9.623

8.  Hypotensive effect of atorvastatin in hypertensive patients: the association among flow-mediated dilation, oxidative stress and endothelial dysfunction.

Authors:  Agnieszka M Tycinska; Jacek Janica; Barbara Mroczko; Wlodzimierz J Musial; Robert Sawicki; Bozena Sobkowicz; Karol Kaminski; Urszula Lebkowska; Maciej Szmitkowski
Journal:  Arch Med Sci       Date:  2011-12-30       Impact factor: 3.318

Review 9.  The Entry and Egress of Monocytes in Atherosclerosis: A Biochemical and Biomechanical Driven Process.

Authors:  Hongyan Kang; Xinyu Li; Kewen Xiong; Zhiyun Song; Jiaxin Tian; Yuqiao Wen; Anqiang Sun; Xiaoyan Deng
Journal:  Cardiovasc Ther       Date:  2021-07-08       Impact factor: 3.023

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.